BioCentury
ARTICLE | Company News

ChromoCure, Genome Research deal

May 17, 2010 7:00 AM UTC

Genome Research completed its previously announced reverse-merger with ChromoCure in a deal that the companies said is valued at $29 million (see BioCentury, May 3). ...